
COVID-19 Human IgA ELISA kit (Spike Protein)(S1)

Specification
Measurement method : Indirect ELISA
Measurement wavelength : 450 nm
Measurement sample : Serum, saliva, sputum
Species reactivity : Human
Storage temperature : Store at 2-8° C.
Expiration date : 12 months after production
Immobilized antigen : SARS-CoV-2 Spike protein (S1 domain, E. coli expression system)
Kit contents
1. SARS-CoV-2 spike protein(S1)-immobilized plate
2. HRP-conjugated anti-human IgA antibody
3. Washing buffer(10× PBST)
4. Bovine serum albumin (for diluent buffer)
5. Diluent buffer (10×)
6. R-1: Chromogenic substrate (TMB)
7. R-2: Stop reagent (1 mol/L hydrochloric acid)
8. Microplate seal
×1
10 μL×1
100 mL×1
×1
50 mL×1
22 mL×1
22 mL×1
×2
Measurement principle
-
The SARS-CoV-2 recombinant spike protein (S1) immobilized on the plate is recognized and reacted with the antibody (hereinafter, abbreviated as anti-spike protein antibody) in a sample.
-
After the reaction, the sample is removed by washing.
-
The anti-spike protein antibody is reacted with HRP (Horseradish peroxidase)-conjugated anti-human IgA antibody
-
Remove excess HRP-conjugated anti-human IgA antibody by washing. Add a chromogenic substrate and measure the absorbance.
.png)
Significance of measurement
This kit is a research ELISA kit to detect human IgA antibody that recognizes the spike protein of SARS-CoV-2, the causative virus of Covid-19.
Virus detection can be broadly divided into two approaches: one is to detect the virus itself, such as PCR method, and the other is to detect the immune response that develops during infection (IgG, IgM, IgA). IgA is particularly abundant in mucous membranes such as saliva and the nasopharynx, and generally has the function of infection prevention.
Related literature
-
Radosław Rzepliński et al.
Dynamics of humoral response to coronavirus antigens among employees of COVID-dedicated hospital: an observational study
Pol Arch Intern Med. 2021 Jun. PubMed PMID: 34100280
-
Detlef Kindgen-Milles et al.
Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV)
PLoS One. 2021 Apr. PubMed PMID: 33831032
-
Denise J. McCulloch et al.
Seroprevalence of SARS-CoV-2 antibodies in Seattle, Washington: October 2019–April 2020
PLoS One. 2021 May. PubMed PMID: 34043706
-
Jiufeng Sun et al.
The kinetics of viral load and antibodies to SARS-CoV-2
Clin Microbiol Infect. 2020 Dec. PubMed PMID: 32898715
-
Hans Verkerke et al.
Are We Forgetting About IgA? A Re-examination of Coronavirus Disease 2019 Convalescent Plasma
Transfusion. 2021 May. PubMed PMID: 34041759
-
Marie-Luise Buchholtz et al.
SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS
PLoS One. 2021 May. PubMed PMID: 33984048
-
Kissy Guevara-Hoyer et al.
Serological Tests in the Detection of SARS-CoV-2 Antibodies
Diagnostics (Basel). 2021 Apr. PubMed PMID: 33918840
-
Megan Zilla et al.
Variable Performance in 6 Commercial SARS-CoV-2 Antibody Assays May Affect Convalescent Plasma and Seroprevalence Screening
Am J Clin Pathol. 2021 Feb. PubMed PMID: 33155015
-
Anna Christine Nilsson et al.
Comparison of six commercially available SARS-CoV-2 antibody assays-Choice of assay depends on intended use
Int J Infect Dis. 2021 Feb. PubMed PMID: 33310021
-
Robert Needle et al.
Serological Evaluation of Human Antibodies of the Immunoglobulin Class A and G Against SARS-CoV-2 in Serum Collected in Newfoundland and Labrador
Viral Immunol. 2021 Mar. PubMed PMID: 33739895
-
Daniëlle A. T. Hanssen et al.
Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples
Eur J Clin Microbiol Infect Dis. 2021 Mar. PubMed PMID: 33733395
-
Angela Chiereghin et al.
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19
Front Public Health. 2021 Feb. PubMed PMID: 33681115
-
Alix T. Coste et al.
Comparison of SARS-CoV-2 serological tests with different antigen targets
J Clin Virol. 2021 Jan. PubMed PMID: 33253926
-
Jan Van Elslande et al.
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs
Clin Microbiol Infect. 2020 Nov. PubMed PMID: 32745595
-
Anna Schaffner et al.
Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: a population-based study
Clin Chem Lab Med. 2020 Nov. PubMed PMID: 33554502
-
Susanne Brandstetter et al.
Symptoms and immunoglobulin development in hospital staff exposed to a SARS‐CoV‐2 outbreak
Pediatr Allergy Immunol. 2020 Oct. PubMed PMID: 32413201
Eur J Clin Microbiol Infect Dis. 2021 Feb. PubMed PMID: 33534090
-
Evangelos Terpos et al.
Anti–SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study
Microorganisms. 2020 Dec. PubMed PMID: 33260775
-
N. Davidson et al.
Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort
Pathology. 2020 Dec. PubMed PMID: 33070955
-
Victoria Indenbaum et al.
Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis
PLoS One. 2020 Nov 23. PubMed PMID: 33227020
-
Baweleta Isho et al.
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
Sci Immunol. 2020 Oct 8. PubMed PMID: 33033173
-
Anges Yadouleton et al.
Limited Specificity of Serologic Tests for SARS-CoV-2 Antibody Detection, Benin
Emerg Infect Dis. 2020 Dec 1. PubMed PMID: 33261717
-
Martin Risch et al.
Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation
Biomed Res Int. 2020. PubMed PMID: 33224987
-
Adrian M Shields et al.
Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
medRxiv. Preprint. 2020 Nov 16. PubMed PMID: 33236029
-
Guillaume Beaudoin-Bussières et al.
Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
mBio. 2020 Oct 16. PubMed PMID: 33067385
-
Pedro Martínez-Fleta et al.
SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals
J Immunol. 2020 Nov 4. PubMed PMID: 33148714
-
Eshan U Patel et al.
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers
J Clin Microbiol. 2020 Nov 2. PubMed PMID: 33139419
-
Zahra Rikhtegaran Tehrani et al.
Performance of nucleocapsid and spike-based SARS-CoV-2 serologic assays
PLoS One. 2020 Nov 2. PubMed PMID: 33137138
-
Meret Huber et al.
Postinfectious Onset of Myasthenia Gravis in a COVID-19 Patient
Front Neurol. 2020 Oct 6. PubMed PMID: 33123081
-
Bernd Jahrsdörfer et al.
Independent side-by-side validation and comparison of four serological platforms for SARS-CoV-2 antibody testing
J Infect Dis. 2020 Oct 16. PubMed PMID: 33064789
-
Manuela Pegoraro et al.
Evaluation of three immunochromatographic tests in COVID-19 serologic diagnosis and their clinical usefulness
Eur J Clin Microbiol Infect Dis. 2020 Oct 20. PubMed PMID: 33078222
-
Suliman A Alharbi et al.
Enzyme-Linked Immunosorbent Assay for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgM/IgA and IgG Antibodies Among Healthcare Workers
Cureus. 2020 Sep 6. PubMed PMID: 33047077
-
Gláucia Cota et al.
Diagnostic performance of commercially available COVID-19 serology tests in Brazil
Int J Infect Dis. 2020 Oct 9. PubMed PMID: 33039612
-
Pauline H Herroelen et al.
Humoral Immune Response to SARS-CoV-2
Am J Clin Pathol. 2020 Aug 18. PubMed PMID: 32808976
-
Georg M. N. Behrens et al.
Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals
Infect Dis Ther. 2020 Sep 4. PubMed PMID: 32886335
-
Clarence W Chan et al.
Analytical and Clinical Evaluation of the Automated Elecsys Anti–SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer
Am J Clin Pathol. 2020 Aug 20. PubMed PMID: 32814955
-
Fleur Wolff et al.
Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays
Diagn Microbiol Infect Dis. 2020 Nov. PubMed PMID: 32829098
-
Sonny Elizaldi et al.
SARS-CoV-2 infection induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques
Res Sq. 2020 Aug 14. PubMed PMID: 32818217
-
Verena Haselmann et al.
Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing
Clin Chem Lab Med . 2020 Aug 27. PubMed PMID: 32853163
-
Maria Infantino et al.
Closing the Serological Gap in the Diagnostic Testing for COVID‐19: The Value of Anti‐SARS‐CoV‐2 IgA Antibodies
J Med Virol. 2020 Aug 13. PubMed PMID: 32790181
-
Felipe Pérez-García et al.
Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study
J Clin Virol. 2020 Aug. PubMed PMID: 32504945
-
Andrea Padoan et al.
IgA-Ab Response to Spike Glycoprotein of SARS-CoV-2 in Patients With COVID-19: A Longitudinal Study
Clin Chim Acta. 2020 Aug. PubMed PMID: 32343948
-
Kathleen G. Beavis et al.
Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies
J Clin Virol. 2020 Aug. PubMed PMID: 32485620
-
AJ Jääskeläinen et al.
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralization
J Clin Virol. 2020 Aug. PubMed PMID: 32563180
-
David Peterhoff et al.
A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization
Infection. 2020 Aug 21. PubMed PMID: 32827125
-
Zahra Rikhtegaran Tehrani et al.
Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays
medRxiv. 2020 Aug 7. PubMed PMID: 32793933
-
Jitendra Prasad Mathuria et al.
Laboratory diagnosis of SARS-CoV-2 - A review of current methods
J Infect Public Health. 2020 Jul. PubMed PMID: 32534946
-
Fatima Amanat et al.
A serological assay to detect SARS-CoV-2 seroconversion in humans
Nat Med. 2020 Jul. PubMed PMID: 32398876
-
Mayara Lisboa Bastos et al.
Diagnostic Accuracy of Serological Tests for covid-19: Systematic Review and Meta-Analysis
BMJ. 2020 Jul. PubMed PMID: 32611558
-
Marie Tré‐Hardy et al.
Analytical and clinical validation of an ELISA for specific SARS‐CoV‐2 IgG, IgA, and IgM antibodies
J Med Virol. 2020 Jul 27. PubMed PMID: 32667733
-
Anita S. Iyer et al.
Dynamics and significance of the antibody response to SARS-CoV-2 infection
medRxiv. Preprint. 2020 Jul 20. PubMed PMID: 32743600
-
Lisa Sophie Pflüger et al.
Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients
J Clin Virol. 2020 Jul 17. PubMed PMID: 32763809
-
Corine H. GeurtsvanKessel et al.
An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment
Nat Commun. 2020 Jul 6. PubMed PMID: 32632160
-
Patrick Sean Sullivan et al.
Detection of SARS-CoV-2 RNA and Antibodies in Diverse Samples: Protocol to Validate the Sufficiency of Provider-Observed, Home-Collected Blood, Saliva, and Oropharyngeal Samples
JMIR Public Health Surveill. 2020 Apr-Jun. PubMed PMID: 32310815
-
Benjamin Meyer et al.
Validation of a commercially available SARS-CoV-2 serological immunoassay
Clin Microbiol Infect. 2020 Jun 27. PubMed PMID: 32603801
-
Jonathan J Deeks et al.
Antibody tests for identification of current and past infection with SARS-CoV-2
Cochrane Database Syst Rev. 2020 Jun 25. PubMed PMID: 32584464
J Clin Virol. 2020 Jun 15. PubMed PMID: 32593133
-
Wan Ni Chia et al.
Serological Differentiation Between COVID-19 and SARS Infections
Emerg Microbes Infect. 2020 Jun 12. PubMed PMID: 32529906
-
Roshan J. D'Cruz et al.
Laboratory Testing Methods for Novel Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
Front Cell Dev Biol. 2020 Jun 4. PubMed PMID: 32582718
-
J Van Elslande et al.
Diagnostic Performance of Seven Rapid IgG/IgM Antibody Tests and the Euroimmun IgA/IgG ELISA in COVID-19 Patients
Clin Microbiol Infect. 2020 May. PubMed PMID: 32473953
-
Huan Ma et al.
Serum IgA, IgM, and IgG responses in COVID-19
Cell Mol Immunol. 2020 May 28. PubMed PMID: 32467617
-
Nadin Younes et al.
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
Viruses. 2020 May 26. PubMed PMID: 32466458
-
Alba Grifoni et al.
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Cell. 2020 May 20. PubMed PMID: 32473127
-
Marie Tré-Hardy et al.
The role of serology for COVID-19 control: Population, kinetics and test performance do matter
J Infect. 2020 May 15. PubMed PMID: 32417311
-
Anne J Jääskeläinen et al.
Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples
Euro Surveill. 2020 May 7. PubMed PMID: 32400364
-
Nisreen M A Okba et al.
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients
Emerg Infect Dis. 2020 Apr 8. PubMed PMID: 32267220
References
1.)Keiichi Hiramatsu, Standard Textbook of standard microbiology, 11th edition, Medical study (2012)
2.)Andrea Padoan, IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study, Clinica Chimica Acta, 507, 164-166, Aug., 2020
3.)Yin Xia Chao, The role of IgA in COVID-19, Brain, Behavior, and Immunity, 87, Jul., 2020